Endothelial progenitor cells in morbid obesity: Pathogenetic implications

Circulation Journal

Volumn 78, Issue 4, 2014, Pages 977-985

  Graziani, Francesca ^a   Leone, Antonio Maria ^a   Basile, Eloisa ^a   Cialdella, Pio ^a   Tritarelli, Alessandra ^a   Bona, Roberta Della ^a   Liuzzo, Giovanna ^a   Nanni, Giuseppe ^a   Iaconelli, Amerigo ^a   Iaconelli, Antonio ^a   Mingrone, Geltrude ^a   Biasucci, Luigi Marzio ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Diabetes; Endothelial progenitor cell; Obesity; Weight loss

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BIOPSY; BODY MASS; CD34 SELECTION; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBID OBESITY; SMOKING; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; BARIATRIC SURGERY; CAROTID ARTERIES; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; STEM CELLS; TUNICA INTIMA;

EID: 84897831374     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0976     Document Type: Article

References (39)

1. Després JP. Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox? J Am Coll Cardiol 2011; 57: 1887-1889.
2. Bender R, Trautner C, Spraul M, Berger M. Assessment of excess mortality in obesity. Am J Epidemiol 1998; 147: 42-48.
3. Poirier P, Alpert MA, Fleisher LA, Thompson PD, Sugerman HJ, Burke LE, et al; American Heart Association Obesity Committee of Council on Nutrition, Physical Activity and Metabolism, Council on Cardiopulmonary Perioperative and Critical Care, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Council on Clinical Cardiology. Evaluation and management of severely obese patients undergoing surgery: A science advisory from the American Heart Association. Circulation 2009; 120: 86-95.
4. Warnes CA, Roberts WC. The heart in massive (more than 300 pounds or 136 kilograms) obesity: Analysis of 12 patients studied at necropsy. Am J Cardiol 1984; 54: 1087-1091.
5. Dufou J, Virmani R, Rabin I, Burke A, Farb A, Smialek J. Sudden death as a result of heart disease in morbid obesity. Am Heart J 1995; 130: 306-313.
6. Kortelainen ML. Myocardial infarction and coronary pathology in severely obese people examined at autopsy. Int J Obes Relat Metab Disord 2002; 26: 73-79.
7. Chan WC, Koelmeyer T. Polysarcia adiposa: Morbid obesity. Am J Forensic Med Pathol 2007; 28: 249-254.
8. Kortelainen ML, Porvari K. Extreme obesity and associated cardiovascular disease verifed at autopsy: Time trends over 3 decades. Am J Forensic Med Pathol 2011; 32: 372-377.
9. Biasucci LM, Graziani F, Rizzello V, Liuzzo G, Guidone C, De Caterina AR, et al. Paradoxical preservation of vascular function in severe obesity. Am J Med 2010; 123: 727-734.
10. Bays HE. Adiposopathy: Is "sick fat" a cardiovascular disease? J Am Coll Cardiol 2011; 57: 2461-2473.
11. Leone AM, Valgimigli M, Giannico MB, Zaccone V, Perfetti M, D'Amario D, et al. From bone marrow to the arterial wall: The ongoing tale of endothelial progenitor cells. Eur Heart J 2009; 30: 890-899.
12. Aburakawa Y, Kawabe J, Okada M, Yamauchi A, Asanome A, Kabara M, et al. Prostacyclin stimulated integrin-dependent angiogenic effects of endothelial progenitor cells and mediated potent circulation recovery in ischemic hind limb model. Circ J 2013; 77: 1053-1062.
13. Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, et al. Ultrasonic evaluation of early carotid atherosclerosis. Stroke 1990; 21: 1567-1572.
14. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004 and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23: 75-80.
15. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987.
16. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
17. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45: 1449-1457.
18. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-2786.
19. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, et al. Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195-199.
20. Moon JH, Chae MK, Kim KJ, Kim HM, Cha BS, Lee HC, et al. Decreased endothelial progenitor cells and increased serum glycated albumin are independently correlated with plaque-forming carotid artery atherosclerosis in type 2 diabetes patients without documented ischemic disease. Circ J 2012; 76: 2273-2279.
21. Müller-Ehmsen J, Braun D, Schneider T, Pfster R, Worm N, Wielckens K, et al. Decreased number of circulating progenitor cells in obesity: Benefcial effects of weight reduction. Eur Heart J 2008; 29: 1560-1568.
22. Heida NM, Müller JP, Cheng IF, Leifheit-Nestler M, Faustin V, Riggert J, et al. Effects of obesity and weight loss on the functional properties of early outgrowth endothelial progenitor cells. J Am Coll Cardiol 2010; 55: 357-367.
23. Bellows CF, Zhang Y, Simmons PJ, Khalsa AS, Kolonin MG. Infu-ence of BMI on level of circulating progenitor cells. Obesity 2011; 19: 1722-1726.
24. Rehman J, Considine RV, Bovenkerk JE, Li J, Slavens CA, Jones RM, et al. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 2003; 41: 1408-1413.
25. Westerweel PE, Visseren FL, Hajer GR, Olijhoek JK, Hoefer IE, de Bree P, et al. Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur Heart J 2008; 29: 2808-2817.
26. Jialal I, Devaraj S, Singh U, Huet BA. Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: Implications for increased cardiovascular risk. Atherosclerosis 2010; 211: 297-302.
27. Rehman J, Li J, Parvathaneni L, Karlsson G, Panchal VR, Temm CJ, et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Car-diol 2004; 43: 2314-2318.
28. Humpert PM, Neuwirth R, Battista MJ, Voronko O, von Eynatten M, Konrade I, et al. SDF-1 genotype infuences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes. Diabetes Care 2005; 28: 934-936.
29. Humpert PM, Djuric Z, Zeuge U, Oikonomou D, Seregin Y, Laine K, et al. Insulin stimulates the clonogenic potential of angiogenic en-dothelial progenitor cells by IGF-1 receptor-dependent signaling. Mol Med 2008; 14: 301-308.
30. Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, Galuppo P, et al. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 2007; 100: 434-443.
31. Breen DM, Chan KK, Dhaliwall JK, Ward MR, Al Koudsi N, Lam L, et al. Insulin increases reendothelialization and inhibits cell migration and neointimal growth after arterial injury. Arterioscler Thromb Vasc Biol 2009; 29: 1060-1066.
32. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 Diabetes. N Engl J Med 2012; 366: 1577-1585.
33. Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V, et al. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res 2003; 93: e88-e97, doi:10.1161/01.RES.0000099243.20096.FA.
34. Takahashi M, Suzuki E, Kumano S, Oba S, Sato T, Nishimatsu H, et al. Angiopoietin-1 mediates adipose tissue-derived stem cell-induced inhibition of neointimal formation in rat femoral artery. Circ J 2013; 77: 1574-1584.
35. Miranville A, Heeschen C, Sengenès C, Curat CA, Busse R, Bouloumié A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004; 110: 349-355.
36. Planat-Benard V, Silvestre JS, Cousin B, André M, Nibbelink M, Tamarat R, et al. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 2004; 109: 656-663.
37. Baglioni S, Francalanci M, Squecco R, Lombardi A, Cantini G, Angeli R, et al. Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue. FASEB J 2009; 23: 3494-3505.
38. Schmidt-Lucke C, Fichtlscherer S, Aicher A, Tschöpe C, Schultheiss HP, Zeiher AM, et al. Quantifcation of circulating endothelial progenitor cells using the modifed ISHAGE protocol. PLoS One 2010; 5: e13790, doi:10.1371/journal.pone.0013790.
39. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: Risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925-1932.